Atlas Trials

Study to Evaluate the Effect of Nicotinamide Mononucleotide (NMN) As an Adjuvant to Standard of Care (SOC) On Fatigue Associated With COVID-19 Infection

Clinical trial NCT05175768 · TERMINATED

Trial details

NCT number
NCT05175768
Sponsor
Vedic Lifesciences Pvt. Ltd.
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19 Infection
Start date
2021-12-27
Primary completion
2022-07-16
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.